Henry S H Chan

10PUBLICATIONS
18CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Molecular targetsGenetically modified animals
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
An Equity-Embedded, Protocol-Agnostic Pre-Trial Navigation Model for Canadian Blood Cancer Trials: Findings from the Myeloma Canada Phase 0 Workshop.

|Nov 18, 2025
Clinical outcomes and healthcare resource use in triple-class exposed patients with relapsed/refractory multiple myeloma.

Victor H Jimenez-Zepeda, Winson Y Cheung, Mariet Mathew Stephen

|Apr 24, 2023
Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma.

Benjamin W Teh, Gemma Reynolds, Monica A Slavin

|Apr 07, 2022
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma.

Tycel Phillips, Henry Chan, Constantine S Tam

|Nov 23, 2021
Retrospective Analysis of the Effectiveness of a Reduced Dose of Idarucizumab in Dabigatran Reversal.

Louisa Stone, Eileen Merriman, Merit Hanna

|Oct 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.

Katherine Creeper, Bradley Augustson, Kieran Kusel

Pageof 2

Frequent Collaborators

1 joint publications

Alejandro Berlin

1 joint publications

Normand Laperriere

1 joint publications

Katherine Creeper

1 joint publications

Jeff Szer